作者:Stone Fox Capital编译:美港股观察社Hims & Hers Health推出新产品引发市场关注,但上周该股股价却因与CEO相关的争议出现下跌。这家公司正持续扩充其健康产品线,助力实现2030年65亿美元的营收目标。但在公司上月密集推出多款新产品、业务持续扩张的背景下,股价近期还出现了下跌。更年期产品上市周三,公司因推出更年期及围绝经期产品,股价应声上涨。当日该股涨幅达16%,...
Source Link作者:Stone Fox Capital编译:美港股观察社Hims & Hers Health推出新产品引发市场关注,但上周该股股价却因与CEO相关的争议出现下跌。这家公司正持续扩充其健康产品线,助力实现2030年65亿美元的营收目标。但在公司上月密集推出多款新产品、业务持续扩张的背景下,股价近期还出现了下跌。更年期产品上市周三,公司因推出更年期及围绝经期产品,股价应声上涨。当日该股涨幅达16%,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.